Public disclosures
Page built 2026-09-29
Data as of 2026-09-29
Search

Khurram Jamil: insider trades

Every open market trade Khurram Jamil has filed with the SEC, when each filing appeared, and how the buys did against the S&P 500 once the filing was public.

Key Facts

  • Khurram Jamil is listed as Chief Medical Officer at GALT.
  • Between 2026-05-28 (28 May 2026) and 2026-07-16 (16 July 2026) Khurram Jamil filed 0 open market buys worth $0 and 5 open market sales worth $371K.
  • None of Khurram Jamil's buys has matured 90 days yet, so there is no return to report.
  • Data as of 2026-09-29 (29 September 2026).
Open market buys 0 $0
Open market sales 5 $371K
Avg vs S&P, 90d n/a 0 scored buys
Beat the S&P n/a 90 days after entry

Would copying Khurram Jamil have paid?

prices as of 2026-09-28

The result. None of Khurram Jamil's buys has matured 90 days yet, so there is no return to report.

Average return of Khurram Jamil's open market buys against the S&P 500.
Days after entryScored buysAvg vs S&PBeat S&PEntry monthst statisticReading
30 days 0 n/a n/a n/a n/a too few trades to tell
90 days 0 n/a n/a n/a n/a too few trades to tell
180 days 0 n/a n/a n/a n/a too few trades to tell

A return curve needs at least 10 scored buys. Khurram Jamil does not have enough yet.

Stocks traded

  1. GALT5 trades, $371K

Every open market trade

as of 2026-09-29
5 trades.
Open market trades filed by Khurram Jamil, newest first.
FiledStockTypeSharesPriceValue90 day vs S&P
16 Jul 2026 GALT sell 16,250 $5.13 $83.3K n/a
30 Jun 2026 GALT sell 4,570 $5.00 $22.9K n/a
30 Jun 2026 GALT sell 47,467 $5.04 $239K n/a
25 Jun 2026 GALT sell 7,557 $3.14 $23.7K n/a
28 May 2026 GALT sell 568 $3.10 $1.8K n/a

Insider sales are shown but not scored, because they are often planned for tax or diversification reasons.

Frequently asked questions

What has Khurram Jamil bought and sold?

Between 2026-05-28 (28 May 2026) and 2026-07-16 (16 July 2026) Khurram Jamil filed 0 open market buys worth $0 and 5 open market sales worth $371K.

Did Khurram Jamil's buys beat the market?

None of Khurram Jamil's buys has matured 90 days yet, so there is no return to report. Insider sales are not scored because they are often planned for tax or diversification reasons.

Sources: Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.

Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.